Quero-Hernández A, Hernández AJ, Reyes GU, Álvarez SRM, Vargas M, Tenorio RH

Language: Spanish
References: 23
Page: 109-113
PDF size: 49.28 Kb.

ABSTRACT

Introduction: The prognosis of patients with Wilm’s tumor has improved, especially those with favorable histologic pattern or early stages, while the unfavorable histology are even reduced. The purpose of this work was to analysis, the clinical features and answer to treatment in a group of patients with Wilm’s tumor.
Material and methods: This is a retrospective study that analysis the clinical features, histopathology, surgery, treatment response and disease-free survival of 20 clinical cases encountered over a period of 10 years.
Results: 60% of the cases were male with a mean age of 3.5 years. 70% had favorable histopathology and 30% were settled in late stages (III-IV). In 9 patients (45%) underwent chemotherapy before biopsy and tumor resection. Disease-free survival at 5 years, favorable histology group was 72% and unfavorable histology group was 34%.
Conclusions: Diagnosis of Wilm’s tumor has been made in late stages, as it happens in our environment. It is clear that we have to implement mandatory actions, to make an opportune diagnosis, and as a result a feasible treatment in early stages.

REFERENCES

1. Ries LAG, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Horner MJ, Howlader N, Eisner MP, Reichman M, Edwards BK, editors. SEER Cancer Statistics Review 1975-2007. Bethesda: National Cancer Institute; 2007.

2. Rivera LR, Leal LC, Cárdenas CR. A survey of 4,706 children with cancer. Certain epidemiological aspects from a single Institution. Bol Med Hosp Infant Mex 1996; 53: 598-604.

3. Quero-Hernández A, Coronado DR, Pérez-Bautista A, Reyes GU. Neoplasias malignas en niños en dos hospitales del estado de Oaxaca, México (1996-2002). Acta Pediatr Mex 2006; 27(4): 183-9.

4. Green DM, Breslow NE, Beckwith JB, Ritchey ML, Shamberger RC, Haase GM, D’Angio GJ et al. Treatment with nephrectomy only for small, stage I/favorable histology Wilms’ tumor: A report from the National Wilms’ Tumor Study Group. J Clin Oncol 2001; 19: 3719-3724.

5. Metzger ML, Dome JS. Current therapy for Wilms´ tumor. The Oncologist. 2005; 10: 815-826.

6. Weirich A, Leuschner I, Harms D, Vujanic GM, Troger J, Abel U et al. Clinical impact of histologic subtypes in localized non-anaplastic nephroblastoma treated according to the trial and study SIOP-9/GPOH. Ann Oncol 2001: 311-319.

7. Weirichi A, Ludwing R, Graf N, Abel U, Leuschner I, Vujanics GM et al. Survival in nephroblastoma treated according to the trial and study SIOP-9/GPOH with respect to relapse and morbidity. Ann Oncol 2004; 15: 808-820.

8. Jones KP. Controversies and advances in the management of Wilms´ tumour. Arch Dis Child 2002; 87: 241-244.

9. Jones PA, Kelsey AG, Vujanic GJ, Imeson C, Mitchell C. Older age is an adverse prognostic factor in stage I, favorable histology Wilms´ tumor treated with vincristine, monochemotherapy: A study by the United Kingdom Children´s Cancer Study Group, Wilms´ Tumor Working Group. J Clin Oncol 2003; 21: 3269-3275.

10. Dome JS, Cotton CA, Perlman EJ, Breslow NE, Kalapurakal JA, Ritchey ML et al. Treatment of anaplasic histology Wilms´ tumor: Results from the Fifth National Wilms´ Tumor Study. J Clin Oncol 2006; 24: 2352-2358.

11. Beckwithm JB, Palmer NF. Histopathology and prognosis of Wilms tumor. Cancer 1978; 41: 1937-1948.

12. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.

13. Pastore G, Carli M, Lemerle J, Tournade MF, Voute PA, Rey A et al. Epidemiological features of Wilms´tumor: results of studies by the International Society of Paediatric Oncology (SIOP). Med Pediatr Oncol 1988; 16(1): 7-11.

14. Kalapurakal JA, Dome JS, Perlman EJ, Malogolowkin M, Haase GM, Grundy P et al. Management of Wilms´tumour: current practice and future goals. Lancet Oncol 2004; 5: 37-46.

15. Breslow N, Beckwith JB, Ciol M, Sharples K. Age distribution of Wilms´tumor: report from the National Wilms´ Tumor Study. Cancer Res 1988; 48(6): 1653-1657.

16. Jones P, Kelsey A, Vujanic J, Imeson J, Hutton C, Mitchell C. Older age is an adverse prognostic factor in stage I, favorable histology Wilms´tumor treated with vincristina monochemotherapy: a study by the United Kingdom Children´s Cancer Study Group, Wilms´Tumor Working Group. J Clin Oncol 2003; 21(17): 3269-3275.

17. Tucci S, Cologna AJ, Suaid HJ, Valera ET, Tirapelli LF, Paschoalin EL et al. Results of novel strategies for treatment of Wilms´ tumor. International Braz J Urol 2007; 33(2): 195-203.

18. Grundy P, Telzerow P, Moksness J et al. Clinicopathologic correlates of loss of heterozygosity in Wilms´ tumor: a preliminary analysis. Med Pediatr Oncol 1996; 27: 429-433.

19. Camassei FD, Ferlini C, Jenkner A, Bosman C, Biselli R, Donfrancesco A et al. Nephroblastoma. DNA characteristics and their modifications induced by prenephrectomy chemotherapy: a cytofluorimetric study. Pediatr Pathol Mol Med 2002; 21(1): 15-23.

20. Green DM. The treatment of stages I-IV favorable histology Wilms´ tumor. J Clin Oncol 2004; 22(8): 1366-1372.

21. Covarrubias EG, Bojórquez S, López CG. Tumor de Wilms. Experiencia en el diagnóstico y tratamiento de 19 niños. Rev Mex Pediatr 2000; 67(6): 252-254.

22. Pritchard J. Controversies and advances in the management of Wilms´ tumour. Arch Dis Child 2002; 87: 241-244.

23. Hall G, Grant R, Weitzman S, Maze R, Greenberg M, Gerstle JT. Predictors of surgical outcome in Wilms´ tumor: a single-institution comparative experience. J Pediatr Surg 2006; 41(5): 996-971.